Live Breaking News & Updates on Mauna kea trask

Mauna Kea Technologies Announces the Appointment of Sacha Loiseau as Chief Executive Officer

Regulatory News: Mauna Kea Technologies (Euronext: MKEA) (Paris:MKEA) (OTCQX:MKEAY), inventor of Cellvizio, the multi-disciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform

Paris , France-general , France , Mauna-kea , Mauna-kea-technologie , Nicolas-bouvier , Christopherd-mcfadden , Tasly-pharma , Thomas-grojean , Mauna-kea-techonologie , Sacha-loiseau , Telix-pharmaceuticals

Mauna Kea Technologies Postpones Release of its 2022 Half-Year Financial Results

Regulatory News: Mauna Kea Technologies (Euronext: MKEA) (Paris:MKEA) (OTCQX:MKEAY), inventor of Cellvizio, the multi-disciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform

Paris , France-general , France , Thomas-grojean , Mauna-kea-techonologie , Mauna-kea-technologie , Regulatory-news , Kea-technologies , Year-results , Mauna-kea-technologies , Registration-document

Mauna Kea Technologies Publishes Q1 2022 Sales and Its 2021 Financial Results

Following its 2021 restructuring, Company experiences stable U.S sales growth, including improved gross margin and anticipated reductions in operating losses Webinar april 21st 2022 at 7:00 pm https://us02web.zoom.us/webinar/register/WN KuWBx3iYSMyew6PkI3LfeA Regulatory

United-states , Paris , France-general , France , Ukraine , Mauna-kea , Thomas-grojean , Asia-pacific , Kepler-cheuvreux , Mauna-kea-technologie , Nicolas-bouvier , Armistice-master-fund-ltd

Mauna Kea Technologies Announces First of Its Kind U.S. FDA 510(k) Clearance for Use of Cellvizio in a New Category of Molecular Imaging-guided Endoscopic, Laparoscopic, Needle-Based Procedures

Completion of a Major Regulatory Milestone for Molecular Imaging and Precision Medicine as Part of Ongoing Collaboration Regulatory News: Mauna Kea Technologies (Euronext: MKEA, 'Mauna Kea')

Thomas-grojean , Mauna-kea , Mauna-kea-technologie , Nicolas-bouvier , International-agency-for-research-on-cancer , French-financial-markets-authority-autorit , World-health-organization , Major-regulatory-milestone , Molecular-imaging , Precision-medicine , Kea-technologies

Mauna Kea Technologies to Present at 32nd Annual Oppenheimer Healthcare Conference on March 17, 2022

Regulatory News: Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced that

Thomas-grojean , Mauna-kea-technologie , Sacha-loiseau , French-financial-markets-authority-autorit , Regulatory-news , Kea-technologies , Annual-oppenheimer-healthcare , Mauna-kea-technologies , Registration-document , French-financial-markets-authority , Mauna , Echnologies